BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26363973)

  • 41. Protective effect of genistein on lipopolysaccharide/D-galactosamine- induced hepatic failure in mice.
    Lin X; Zhang S; Huang R; Wei L; Liang C; Chen Y; Lv S; Liang S; Wu X; Huang Q
    Biol Pharm Bull; 2014; 37(4):625-32. PubMed ID: 24818258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
    Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Humulus japonicus Extracts Protect Against Lipopolysaccharide/d-Galactosamine-Induced Acute Liver Injury in Rats.
    Bae J; Min YS; Nam Y; Lee HS; Sohn UD
    J Med Food; 2018 Oct; 21(10):1009-1015. PubMed ID: 30334699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
    Tang F; Fan K; Wang K; Bian C
    Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of monoammonium glycyrrhizinate and cysteine hydrochloride ameliorated lipopolysaccharide/galactosamine-induced acute liver injury through Nrf2/ARE pathway.
    Chu S; Niu Z; Guo Q; Bi H; Li X; Li F; Zhang Z; He W; Cao P; Chen N; Sun X
    Eur J Pharmacol; 2020 Sep; 882():173258. PubMed ID: 32544505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-sitosterol and its derivatives repress lipopolysaccharide/d-galactosamine-induced acute hepatic injury by inhibiting the oxidation and inflammation in mice.
    Yin Y; Liu X; Liu J; Cai E; Zhu H; Li H; Zhang L; Li P; Zhao Y
    Bioorg Med Chem Lett; 2018 May; 28(9):1525-1533. PubMed ID: 29622518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
    Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
    Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal Stem Cells Modified with Heme Oxygenase-1 Have Enhanced Paracrine Function and Attenuate Lipopolysaccharide-Induced Inflammatory and Oxidative Damage in Pulmonary Microvascular Endothelial Cells.
    Chen X; Zhang Y; Wang W; Liu Z; Meng J; Han Z
    Cell Physiol Biochem; 2018; 49(1):101-122. PubMed ID: 30153667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diallyl sulfide protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice.
    Li M; Wang S; Li X; Jiang L; Wang X; Kou R; Wang Q; Xu L; Zhao N; Xie K
    Food Chem Toxicol; 2018 Oct; 120():500-509. PubMed ID: 30075314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.
    Dong L; Yin L; Quan H; Chu Y; Lu J
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29057809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice.
    Xing WW; Zou MJ; Liu S; Xu T; Gao J; Wang JX; Xu DG
    Cytokine; 2011 Nov; 56(2):174-9. PubMed ID: 21843953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model.
    Raish M; Ahmad A; Alkharfy KM; Ahamad SR; Mohsin K; Al-Jenoobi FI; Al-Mohizea AM; Ansari MA
    BMC Complement Altern Med; 2016 Dec; 16(1):501. PubMed ID: 27912738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatoprotective effect of 3-alkynyl selenophene on acute liver injury induced by D-galactosamine and lipopolysaccharide.
    Wilhelm EA; Jesse CR; Roman SS; Nogueira CW; Savegnago L
    Exp Mol Pathol; 2009 Aug; 87(1):20-6. PubMed ID: 19344711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway.
    Ai G; Wu X; Dou Y; Huang R; Zhong L; Liu Y; Xian Y; Lin Z; Li Y; Su Z; Chen J; Qu C
    Food Chem Toxicol; 2022 Aug; 166():113215. PubMed ID: 35691465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatoprotective effect of germanium-containing Spirulina in rats with (D)-galactosamine- and lipopolysaccharide-induced hepatitis.
    Yoshinari O; Shiojima Y; Igarashi K
    Br J Nutr; 2014 Jan; 111(1):135-40. PubMed ID: 23768655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
    Zhu Y; Chen X; Rao X; Zheng C; Peng X
    Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats.
    Choi JH; Kang JW; Kim DW; Sung YK; Lee SM
    Eur J Pharmacol; 2011 Apr; 657(1-3):138-43. PubMed ID: 21284943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice.
    Wang H; Xu DX; Lv JW; Ning H; Wei W
    Toxicology; 2007 Jul; 237(1-3):49-57. PubMed ID: 17602819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response.
    Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q
    Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.